Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Reaffirms 2008 Guidance, Expects 5 Percent Revenue Growth in '09

NEW YORK (GenomeWeb News) – Beckman Coulter today reaffirmed its revenue and earnings-per-share outlook for 2008 and provided preliminary guidance for 2009.
The firm said that it still expects to report revenue growth of around 12 percent for fiscal 2008, with earnings per share in a range between $3.55 and $3.65.
It also provided preliminary guidance for 2009, saying that it expects revenue growth of approximately 5 percent on a constant currency basis. Beckman expects its cash instrument sales to be flat to slightly down, “against unusually high sales levels in 2008,” for 2009.
The firm noted that it has “implemented a zero overhead growth policy to control expenses,” and it expects to achieve its earnings-per-share growth in 2009 of 10 percent.
Beckman’s forecast stands in contrast to several other firms that sell capital equipment into the life sciences and diagnostics fields. Last week, Waters and MDS lowered their revenue expectations for the current quarter, and Agilent lowered its guidance for 2009.
In addition, investment bank Leerink Swann downgraded the stocks of several life science tool firms, citing tighter budgets for academic customers.
In late Tuesday afternoon trade, shares of Beckman were up 11 percent at $41.40 on the New York Stock Exchange.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.